TLCR Reading Tools
How to cite item
Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{46077}, author = {Takeuchi, S., Yanagitani, N., Seto, T., Hattori, Y., Ohashi, K., Morise, M., Matsumoto, S., Yoh, K., Goto, K., Nishio, M., Takahara, S., Kawakami, T., Imai, Y., Yoshimura, K., Tanimoto, A., Nishiyama, A., Murayama, T., Yano, S.}, title = {Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)}, journal = {Translational Lung Cancer Research}, volume = {10}, number = {1}, year = {2020}, url = {https://tlcr.amegroups.org/article/view/46077} }